Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 3, 2022

View Archived Issues

Tyrosine kinase inhibitor NTRC-0652-0 shows promise for the treatment of cholangiocarcinoma

New prolyl endopeptidase inhibitors identified at Accure Therapeutics

ReViral describes new compounds for respiratory syncytial virus infections

Mcl-1 inhibitors discovered at Janssen

3M Innovative Properties divulges new Toll-like receptor 7 agonists

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Bcl-2 and/or Bcl-X inhibitors

Endothelial BCAR1 expression associated with antiangiogenic therapy resistance

Discovery of novel MBL inhibitors as promising beta-lactam antibiotics

Epigenetic-mediated immune mechanisms identified in TB

A microbiota-macrophage-iron axis regulates hematopoietic stem cell fate decisions under stress

A comprehensive catalog of functional cell types and cellular states in human brain metastases

Targeting PPARalpha-ACOT12 axis as a potential new therapeutic strategy for osteoarthritis

PLA2-IIA modulates immunity through its interaction with microbiota

CIRM grant supports Juvena's preclinical work on JUV-161 for myotonic dystrophy type 1

Brickell licenses rights to Carna's STING antagonists for autoimmune and inflammatory diseases

Anakuria's AT-20494 to be studied for ADPKD and other indications

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...